尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Warner Robert Keith, 董事. Officer active across 2 companies, notably RxSight, Inc.. Cumulatively, 13 reports have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €1.1m. History available since 3 August 2021. The latest transaction was filed on 24 April 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 条申报中的 13 条
Warner Robert Keith is an Administrateur and reports transactions for RxSight, Inc. and Inari Medical, Inc. Across 13 filings, the 13 sampled filings cover the period from 2021-08-05 to 2025-06-04, with sum_buy_eur at 0 and sum_sell_eur at 1110519. The main sampled filings include sales of EUR 640078.7811136732 on 2024-01-09 at RxSight, Inc. and EUR 470440.6750128144 on 2023-12-12 at RxSight, Inc., as well as Attribution-type transactions at Inari Medical, Inc. and RxSight, Inc.